This brand name is authorized in Austria, Canada, Estonia, Finland, Croatia, Ireland, Lithuania, Poland, Romania, United Kingdom, United States
The drug DAURISMO contains one active pharmaceutical ingredient (API):
|
1
Glasdegib
UNII TH2EV99S4Z - GLASDEGIB MALEATE
|
|
Glasdegib is an inhibitor of the Hedgehog (Hh) signal transduction pathway that binds to Smoothened (SMO), a transmembrane protein, leading to decreased Glioma-Associated Oncogene (GLI) transcription factor activity and downstream pathway signalling. Hh pathway signalling is required for maintaining a leukaemic stem cell (LSC) population thus, glasdegib binding to and inhibiting SMO reduces GLI1 levels in AML cells and the leukaemic initiating potential of AML cells. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| DAURISMO Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| DAURISMO Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L01XJ03 | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XJ Hedgehog pathway inhibitors | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: CA | Health Products and Food Branch | Identifier(s): 02498472, 02498480 |
| Country: EE | Ravimiamet | Identifier(s): 1821956, 1821967 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 140223, 512958 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 386990, 386995 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1090735, 1090736, 1090737, 1090738 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100439187, 100439193 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W67083001, W67083002, W67085001, W67085002 |
| Country: US | FDA, National Drug Code | Identifier(s): 0069-0298, 0069-1531 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
